Correlation Between Talis Biomedical and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Talis Biomedical and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talis Biomedical and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Talis Biomedical Corp and Vivos Therapeutics, you can compare the effects of market volatilities on Talis Biomedical and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talis Biomedical with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talis Biomedical and Vivos Therapeutics.

Diversification Opportunities for Talis Biomedical and Vivos Therapeutics

-0.4

Correlation Coefficient

Talis Biomedical  Vivos Therapeutics

Very good diversification

The 3 months correlation between Talis and Vivos is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Talis Biomedical Corp and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Talis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talis Biomedical Corp are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Talis Biomedical i.e., Talis Biomedical and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Talis Biomedical and Vivos Therapeutics

If you would invest  268.00  in Vivos Therapeutics on September 2, 2024 and sell it today you would earn a total of  73.00  from holding Vivos Therapeutics or generate 27.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	0.0%
Values	Daily Returns

Talis Biomedical Corp  vs.  Vivos Therapeutics

Talis Biomedical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vivos Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Talis Biomedical and Vivos Therapeutics

The main advantage of trading using opposite Talis Biomedical and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talis Biomedical position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind Talis Biomedical Corp and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.